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Introduction 
Heinrich Koebner first described the isomorphic 
phenomenon in 1872. Koebnerization has been 
described to be associated with a myriad of 
dermatoses and elicitors, whereas true Koebnerization 
is reserved for cases of isomorphic lesion formation 
after an external injury and is classically linked to 
psoriasis [1, 2]. The isotopic response of Wolf is a 
condition characterized by the appearance of a new 
dermatosis on the same place as that of healed 
cutaneous lesions [7]. In current medical practice, 
warfarin, a vitamin K antagonist, is one of the most 
frequently used anticoagulants for primary and 
secondary prevention of thromboembolic disorders. 
With a prevalence of 0.01%–0.1%, warfarin-induced 
skin necrosis (WISN) is a rare complication with a high 
morbidity [3]. The presented case describes WSIN 
within psoriatic plaques. 
 
Case Synopsis 
A 41-year-old woman who was overweight and had 
long-standing psoriasis developed an embolic stroke 
owing to aortic valve vegetations and had to 
undergo emergency aortic heart valve replacement 
surgery. She developed psoriasis in her mid-
twenties. After a failed response to methotrexate and 
cyclosporine, etanercept was introduced in 2015 and 
was successful. However, owing to wishing for a child, 
the patient decided to stop etanercept treatment 
three months prior to the stroke. Since then, psoriasis 
was treated with topical corticosteroids. 
Warfarin was introduced immediately after surgery. 
On the third day after surgery, the patient developed 
painful purpuric lesions on the bilateral lower legs. 
Abstract 
A myriad of different phenomena exist in the 
dermatological literature which are based on the 
concept of locus minores resistentiae. The most 
commonly described phenomenon is the Koebner 
phenomenon, which is classically associated with the 
emergence of psoriatic lesions post trauma. Warfarin-
induced skin necrosis (WISN) is a rare but severe side 
effect that leads to necrosis of the skin, 
predominantly on areas with increased 
subcutaneous fat. The presented case reports on 
WISN within psoriatic plaques. 
Figure 1. Hemorrhage and skin necrosis within psoriatic plaques together with non-affected psoriatic plaques A, B) on both thighs, and 
C) on the right forearm. D) There is extensive psoriasis without skin necrosis on the back.
A B C D 
Volume 25 Number 6| June 2019| 
25(6):13 
 
 
- 2 - 
Dermatology Online Journal  ||  Photo Vignette
Over the next few days, the lesions progressed to 
blood-filled blisters with cutaneous necrosis. At the 
time of dermatologic evaluation, severe psoriasis 
was revealed, with a PASI of 18 along with 
hemorrhage into the psoriatic plaques on both 
thighs and on the right forearm (Figure 1). 
Subsequently, the lesions progressed to superficial 
necrosis. The psoriatic plaques of the patient’s back 
were not affected by hemorrhage. 
Biopsies taken from the upper and lower extremities 
showed dermal and subcutaneous vessels 
containing fibrin deposits without inflammatory 
elements together with epidermal necrosis and 
remnant features of psoriasis (Figure 2). Laboratory 
analyses were negative for heparin-induced 
thrombocytopenia and the platelet count was 
normal. Blood cultures remained negative. The level 
of creatinine was increased to 138μmol/L (normal 
range 45-90μmol/L) and that of calcium was 
1.98mmol/L (normal range 2.15-2.55mmol/L). 
Laboratory work-up indicated normal levels of 
protein C, protein S, antithrombin III, and anti-
phospholipid antibodies. 
The diagnosis of WISN within psoriasis, was made. 
Warfarin was discontinued and replaced by heparin; 
thereafter, long-term treatment with warfarin was 
cautiously reinitiated without further complications. 
Topical treatment with 0.1% betamethasone 
valerate for psoriasis was continued and 
secukinumab was introduced three weeks after the 
stroke. The necrotic lesions were regularly dressed 
and they subsequently healed with conservative 
care. 
 
Case Discussion 
Koebner phenomenon has been described to occur 
mainly in psoriasis and other inflammatory 
cutaneous diseases post trauma, but therapeutics, 
including medications, radiation, and phototherapy 
have been documented as Koebner stimuli, in 
addition to inflammatory skin diseases and 
infectious dermatoses [1, 4]. 
Psoriasis as elicitor of another dermatosis seems 
extremely rare. In 1964, Vivkers and Ghadially 
reported on keratoacanthomas arising from psoriatic 
patches [5]. Eruptive lentiginosis in resolving 
psoriatic plaques have been occasionally described 
in the literature and may be called Wolf isotopic 
response [6, 7]. The presented case of WISN within 
psoriatic plaques can be considered as Wolf isotopic 
co-response, which refers to the appearance of a 
disease at the same anatomic site as another still 
active second disease [8]. 
Happle and Kluger, however, recently questioned 
the term Wolf response and argued that the Wolf 
isotopic response is a mere variant of Koebner 
phenomenon and therefore should be abandoned. 
The concept of locus minores resistentiae underlies 
both phenomena in an effort to explain why certain 
locations predispose to disease [9, 10]. 
Warfarin-induced skin necrosis usually appears three 
to eight days after initiating warfarin treatment in 
susceptible individuals. The pathogenesis of WISN is 
not yet fully understood, but a temporary 
hypercoagulable state may result in thrombi 
formation in the skin microvasculature. Further, 
immunologic hypersensitivity to warfarin or a direct 
toxic effect of warfarin and its congeners on the small 
vessels are the possible mechanism of WISN [11]. 
The risk factors are most commonly female sex and 
obesity, followed by deficiency in protein C, protein 
S, or antithrombin III. Areas with abundant 
subcutaneous fatty tissue, such as the breasts and 
thighs, are predominantly affected and 
approximately one third of patients were reported to 
have involvement of multiple sites [3]. The entities in 
Figure 2. Epidermal necrosis together with thrombotic 
vasculopathy including psoriatic skin with elongation of rete 
ridges. H&E, 40×. 
Volume 25 Number 6| June 2019| 
25(6):13 
 
 
- 3 - 
Dermatology Online Journal  ||  Photo Vignette
the differential diagnosis of WISN are calciphylaxis, 
septic or cholesterol microembolization, heparin-
induced skin necrosis as a result of thrombo-
cytopenia, purpura fulminans, and necrotizing 
fasciitis [12]. 
In this present case, cutaneous emboli originating 
from the aortic valve seemed unlikely because the 
necrotic skin lesions appeared three days after the 
removal of the valve. The clinical manifestations, 
temporal connection with warfarin initiation, 
absence of chronic renal failure with nearly normal 
calcium levels, and absence of inflammatory markers 
led to the diagnosis of WISN. The histopathological 
findings of WISN are non-specific. Characteristic 
features, as found in the presented case, were 
described as the presence of thrombi within dermal 
and subcutaneous vessels, resulting in skin ischemia 
without inflammatory features [13]. 
The presented patient belongs to the WISN risk 
group of middle-aged obese women, who are most 
commonly affected by this adverse cutaneous 
reaction [3]. Other hematological contributions were 
not detectable. In addition to the affected lower legs, 
she developed WISN in the pre-existing psoriatic  
plaques on areas with increased subcutaneous fat, 
such as the extremities, with sparing of the back. The 
mechanism of the herein described findings remains 
unclear, but the author hypothesizes that an 
increased blood flow in the papillary dermis of the 
psoriatic lesions and/or local inflammation in the 
psoriatic skin may have triggered WISN. 
 
Conclusion 
Herein, a case of warfarin-induced skin necrosis 
within preexisting psoriatic plaques is shown and 
represents a newly described finding, which can be 
explained by the concept of locus minores 
resistentiae. 
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